|
1
|
Chang PF, Lin YC, Liu K, Yeh SJ and Ni YH:
Identifying term breast-fed infants at risk of significant
hyperbilirubinemia. Pediatr Res. 74:408–412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Moncrieff G: Bilirubin in the newborn:
Physiology and pathophysiology. Br J Midwifery. 26:362–370. 2018.
View Article : Google Scholar
|
|
3
|
Christensen RD, Nussenzveig RH, Yaish HM,
Henry E, Eggert LD and Agarwal AM: Causes of hemolysis in neonates
with extreme hyperbilirubinemia. J Perinatol. 34:616–619. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bjerre JV, Petersen JR and Ebbesen F:
Surveillance of extreme hyperbilirubinaemia in Denmark. A method to
identify the newborn infants. Acta Paediatr. 97:1030–1034. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olusanya BO, Teeple S and Kassebaum NJ:
The contribution of neonatal jaundice to global child mortality:
findings from the GBD 2016 study. Pediatrics. 141:e201714712018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee BK, Le Ray I, Sun JY, Wikman A, Reilly
M and Johansson S: Haemolytic and nonhaemolytic neonatal jaundice
have different risk factor profiles. Acta Paediatr. 105:1444–1450.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Christensen RD and Yaish HM: Hemolytic
disorders causing severe neonatal hyperbilirubinemia. Clin
Perinatol. 42:515–527. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Agarwal V, Singh V, Goel SP and Gupta B:
Maternal and neonatal factors affecting physiological jaundice in
western U.P. Indian J Physiol Pharmacol. 51:203–206.
2007.PubMed/NCBI
|
|
9
|
Wei CC, Chang CH, Lin CL, Chang SN, Li TC
and Kao CH: Neonatal jaundice and increased risk of
attention-deficit hyperactivity disorder: A population-based cohort
study. J Child Psychol Psychiatry. 56:460–467. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maisels MJ and McDonagh AF: Phototherapy
for neonatal jaundice. N Engl J Med. 358:920–928. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Itoh S, Okada H, Kuboi T and Kusaka T:
Phototherapy for neonatal hyperbilirubinemia. Pediatr Int (Roma).
59:959–966. 2017. View Article : Google Scholar
|
|
12
|
Ebbesen F, Madsen PH, Vandborg PK,
Jakobsen LH, Trydal T and Vreman HJ: Bilirubin isomer distribution
in jaundiced neonates during phototherapy with LED light centered
at 497 nm (turquoise) vs. 459 nm (blue). Pediatr Res. 80:511–515.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mreihil K, Benth JS, Stensvold HJ, Nakstad
B and Hansen TWR; Norwegian NICU Phototherapy Study Group;
Norwegian neonatal network, : Phototherapy is commonly used for
neonatal jaundice but greater control is needed to avoid toxicity
in the most vulnerable infants. Acta Paediatr. 107:611–619. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maisels MJ: Phototherapy in the neonatal
intensive care unit-quantity and quality. Acta Paediatr.
107:551–553. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhutani VK and Wong R: Bilirubin-induced
neurologic dysfunction (BIND). Semin Fetal Neonatal Med. 20:12015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zecca E, Barone G, De Luca D, Marra R,
Tiberi E and Romagnoli C: Skin bilirubin measurement during
phototherapy in preterm and term newborn infants. Early Hum Dev.
85:537–540. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaplan M, Hammerman C, Renbaum P, Klein G
and Levy-Lahad E: Gilbert's syndrome and hyperbilirubinaemia in
ABO-incompatible neonates. Lancet. 356:652–653. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiao Y, Jin Y, Meng H and Wen M: An
analysis on treatment effect of blue light phototherapy combined
with Bifico in treating neonatal hemolytic jaundice. Exp Ther Med.
16:1360–1364. 2018.PubMed/NCBI
|
|
19
|
Mreihil K, Madsen P, Nakstad B, Benth JS,
Ebbesen F and Hansen TW: Early formation of bilirubin isomers
during phototherapy for neonatal jaundice: effects of single vs.
double fluorescent lamps vs. photodiodes. Pediatr Res. 78:56–62.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oláh J, Tóth-Molnár E, Kemény L and Csoma
Z: Long-term hazards of neonatal blue-light phototherapy. Br J
Dermatol. 169:243–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sachdeva M, Murki S, Oleti TP and Kandraju
H: Intermittent versus continuous phototherapy for the treatment of
neonatal non-hemolytic moderate hyperbilirubinemia in infants more
than 34 weeks of gestational age: a randomized controlled trial.
Eur J Pediatr. 174:177–181. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lamola AA, Bhutani VK, Wong RJ, Stevenson
DK and McDonagh AF: The effect of hematocrit on the efficacy of
phototherapy for neonatal jaundice. Pediatr Res. 74:54–60. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maisels MJ, Ramaswamy D and Kring EA: Does
phototherapy cause benign skin rashes in newborn infants? Acta
Paediatr. 103:e133–e135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hansen TW: Let there be light - but should
there be less? J Perinatol. 32:649–651. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mills JF and Tudehope D: Fibreoptic
phototherapy for neonatal jaundice. Cochrane Database Syst Rev.
1:CD0020602001.
|
|
26
|
Stokowski LA: Fundamentals of phototherapy
for neonatal jaundice. Adv Neonatal Care. 11 (Suppl 5):S10–S21.
2011. View Article : Google Scholar : PubMed/NCBI
|
